Articles

Using jet injection of insulin instead of conventional pen devices can halve the time required to reach appropriate glucose-lowering effects.…

Data from a retrospective analysis have demonstrated a reduction in the probability for patients with type 2 diabetes to develop heart failure when adding exenatide injection to current treatment. The reduction was particularly noted in those patients receiving insulin….

  The dipeptidyl peptidase (DPP)-4 inhibitor sitagliptin exerts an anti-inflammatory effect in patients with type 2 diabetes at the cellular and molecular level.…

Treatment with Liraglutide reduces insulin dose without loss of glycemic control in type 1 diabetic patients with and without residual beta-cell function.…

In nondiabetic and prediabetic individuals, insulin sensitivity and secretion do not predict spontaneous weight changes; whereas, baseline waist circumference is a positive, independent predictor of weight gain and loss.…

Older type 2’s improve cardiovascular risks when using insulin and targeting postprandial versus fasting glycemia.…

When making a choice amongst GLP-1 Agonists, the number of injections per day and when peak concentrations are reached are both important in selecting therapy. There was almost unanimous consensus that Exenatide is administered twice daily while Liraglutide is given only one time a day. It was interesting to note …

Results will be included in the BYDUREON™ New Drug Application Resubmission in the Third Quarter of 2011….

Outpatient electronic prescribing systems don’t cut out the common mistakes made in manual systems, suggests published research in JAMIA.…

New research from scientists in Canada has revealed that taking aspirin every day could offer benefits for those managing their diabetes….